How by bowing down to short-sighted patient interest pressures the NHS may be harming others:
Funding the drug would mean 355 patients not receiving post-surgery treatment – 16 of whom would be cured, or around 200 patients not receiving palliative chemotherapy.The researchers say there is little long-term data on the clinical benefits and potential dangers of taking Herceptin, whereas the established treatments have been shown to be clinically and cost effective.
Related posts:
- Does alternative medicine work? Or does it harm patients?
- Dangers of herbal medicines
- Adopting hospital quality measures too quickly can harm patients
- Are quality measures doing more harm than good?
- Increasing radiation exposure to patients from CT scans and other imaging tests
- Prostate cancer treatment can shorten penis length
- Lose your fingerprints from chemotherapy
KevinMD.com on Facebook
Comments on this entry are closed.